EATG, EATG, News, News ABIVAX announcements: ABX464 as HIV functional cure and novel treatment for inflammatory disease December 10, 2016 1210
Facebook Twitter Google+ ABIVAX reports new preclinical data supporting ABX464 as HIV functional cure and novel treatment for inflammatory diseases at HIV DART Meeting ABIVAX provides update on clinical development program for ABX464 for functional cure of patients with HIV-infection Original Article Post Views: 1,210 HIV/AIDSResearchTreatment Share the News Facebook Twitter VKontakte Google+ Only 49% transmission rate observed in kidney transplants from HCV-positive donors, but lower graft and survival overall New York reports fewer HIV diagnoses in 2015: target to reduce new infections by 75% by 2020 Related News 1792 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 1700 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2179 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection 1454 Behavioral intervention reduces HIV transmission risk in young transgender women 1891 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 1792 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 1700 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2179 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection 1454 Behavioral intervention reduces HIV transmission risk in young transgender women 1891 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 1792 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe
1891 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
1891 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
